Skip to main content
. 2014 May 22;9(5):e98022. doi: 10.1371/journal.pone.0098022

Figure 4. Subgroup analysis by cancer type of ORs for cancer risk associated with the PARP-1 Val762Ala polymorphism under dominant model (VA+AA vs. VV).

Figure 4